Inflammatory bowel disease (IBD) is a group of disorders characterized by inflammation of the small intestine and colon. The specialists at UC San Diego Health System Inflammatory Bowel Disease Center diagnose and treat people with IBD from around the world.
Our leadership in IBD medical research means that you have access to clinical trials for the newest therapies and advanced surgical techniques for the treatment of this challenging condition.
Contact Us: 858-657-7IBD
Vedolizumab, a new intravenous medication, has shown positive results for treating both Crohn’s disease and ulcerative colitis. The findings appeared in the August 22, 2013 issue of the New England Journal of Medicine.